Page 157 - Genentech News Today

The FDA announced several regulatory actions the past few weeks. Here is an overview of decisions that may be relevant to your practice.

This observational retrospective analysis of prospectively collected data examines whether airway mucus plugs identified on chest computed tomography were assoc

President Joe Biden's nominee to become the new head of the National Institutes of Health (NIH) is the recipient of nearly $300 million in research grants from Pfizer. The nominee in [...]

Many patients with chronic obstructive pulmonary disease (COPD) experience airway-clogging mucus plugs, an accumulation of mucus in the lungs that can affect quality of life and lung functioning. A new study led by researchers from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, has found that mucus plugs were also associated with greater mortality. The findings, published in JAMA and presented simultaneously at the American Thoracic Society 2023...

Glasgow prognostic score appeared associated with survival among patients with small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide, according to study results.No biomarkers are available to predict effectiveness of first-line therapy with atezolizumab (Tecentriq, Genentech) — an anti-PD-L1 antibody — plus carboplatin and etoposide for patients

Sucrose Molecules of sucrose tore apart in their bellies letting glucose course free in their veins.

John V. Heymach, MD, PhD, expands on the efficacy of perioperative durvalumab in the AEGAN trial, the significance of this unique approach for the non–small cell lung cancer treatment paradigm, and future research examining opportunities to build on or intensify the benefit achieved with this regimen.

Fenebrutinib significantly reduced new brain lesions in people with relapsing MS enrolled in the Phase 2 FENopta clinical trial.

In a decision handed down by Associate Justice Neil Gorsuch, the Court held that Amgen "failed to enable any person skilled in the art . . . to make and use the invention as defined by the relevant claims."

/PRNewswire/ -- Today, BLACK ENTERPRISE, the No. 1 Black digital media brand with 12 million unique visitors per month, is thrilled to announce its Future of...